POU5F1 and lip and oral cavity carcinoma: It was shown that piplartine suppressed tumor sphere formation in the oral cancer cells tested, suppressed expression of the SOX2, Oct-4, and NANOG genes associated with stem cells, inhibited cell migration and invasion, and regulated expression of molecules associated with epithelial–mesenchymal transition (EMT).